{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T11:33:22Z","timestamp":1742643202036},"reference-count":22,"publisher":"International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IRDR"],"published-print":{"date-parts":[[2021,8,31]]},"DOI":"10.5582\/irdr.2021.01042","type":"journal-article","created":{"date-parts":[[2021,5,21]],"date-time":"2021-05-21T22:08:51Z","timestamp":1621634931000},"page":"202-206","source":"Crossref","is-referenced-by-count":3,"title":["The coincidence of two ultra-rare hereditary eye diseases: gyrate atrophy and Kjer optic atrophy - a surprising diagnosis based on next-generation sequencing"],"prefix":"10.5582","volume":"10","author":[{"given":"Anna","family":"Skorczyk-Werner","sequence":"first","affiliation":[{"name":"Department of Medical Genetics, Poznan University of Medical Sciences, Poznan, Poland."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorota","family":"Raczynska","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Gdansk Medical University, Gdansk, Poland."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Wawrocka","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, Poznan University of Medical Sciences, Poznan, Poland."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dinara","family":"Zholdybayeva","sequence":"additional","affiliation":[{"name":"West Kazakhstan Marat Ospanow Medical University and &apos;Koz Zharygy&apos; Center, Aktobe, Kazakhstan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nurgul","family":"Yakhiyayeva","sequence":"additional","affiliation":[{"name":"West Kazakhstan Marat Ospanow Medical University and &apos;Koz Zharygy&apos; Center, Aktobe, Kazakhstan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maciej Robert","family":"Krawczynski","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, Poznan University of Medical Sciences, Poznan, Poland."},{"name":"Centers for Medical Genetics &apos;Genesis&apos;, Poznan, Poland."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3542","reference":[{"key":"1","unstructured":"1. Elnahry AG, Tripathy K. Gyrate atrophy of the choroid and retina. <i>https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK557759<\/i> (accessed March 27, 2021)."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Montioli R, Bellezza I, Desbats MA, Borri Voltattorni C, Salviati L, Cellini B. Deficit of human ornithine aminotransferase in gyrate atrophy: Molecular, cellular, and clinical aspects. Biochim Biophys Acta Proteins Proteom. 2021; 1869:140555.","DOI":"10.1016\/j.bbapap.2020.140555"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. M\u00e4ntyj\u00e4rvi M, Tuppurainen K. Colour vision in gyrate atrophy. Vision Res. 1998; 38:3409-3412.","DOI":"10.1016\/S0042-6989(98)00073-X"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Takki KK, Milton RC. The natural history of gyrate atrophy of the choroid and retina. Ophthalmology. 1981; 88:292-301.","DOI":"10.1016\/S0161-6420(81)35031-3"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Kaiser-Kupfer MI, Kuwabara T, Askanas V, Brody L, Takki K, Dvoretzky I, Engel WK. Systemic manifestations of gyrate atrophy of the choroid and retina. Ophthalmology. 1981; 88:302-306.","DOI":"10.1016\/S0161-6420(81)35030-1"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Valtonen M, N\u00e4nt\u00f6-Salonen K, J\u00e4\u00e4skel\u00e4inen S, Hein\u00e4nen K, Alanen A, Heinonen OJ, Lundbom N, Erkintalo M, Simell O. Central nervous system involvement in gyrate atrophy of the choroid and retina with hyperornithinaemia. J Inherit Metab Dis. 1999; 22:855-866.","DOI":"10.1023\/A:1005602405349"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Peltola KE, J\u00e4\u00e4skel\u00e4inen S, Heinonen OJ, Falck B, N\u00e4nt\u00f6-Salonen K, Hein\u00e4nen K, Simell O. Peripheral nervous system in gyrate atrophy of the choroid and retina with hyperornithinemia. Neurology. 2002; 59:735-740.","DOI":"10.1212\/WNL.59.5.735"},{"key":"8","unstructured":"8. Valle D, Simell O. The hyperornithinemias. In: Stanbury JB, Wyngaarden JB, Fredrickson DS, Goldstein JL, Brown MS. (eds.): The Metabolic Basis of Inherited Disease. (5th ed.) New York: McGraw-Hill (pub.) 1983; pp. 382-401."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Shen BW, Hennig M, Hohenester E, Jansonius JN, Schirmer T. Crystal structure of human recombinant ornithine aminotransferase. J Mol Biol. 1998; 277:81-102.","DOI":"10.1006\/jmbi.1997.1583"},{"key":"10","unstructured":"10. Barrett DJ, Bateman JB, Sparkes RS, Mohandas T, Klisak I, Inana G. Chromosomal localization of human ornithine aminotransferase gene sequences to 10q26 and Xp11.2. Invest Ophthalmol Vis Sci. 1987; 28:1037-1042."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Mitchell GA, Looney JE, Brody LC, Steel G, Suchanek M, Engelhardt JF, Willard HF, Valle D. Human ornithine-delta-aminotransferase: cDNA cloning and analysis of the structural gene. J Biol Chem. 1988; 263:14288-14295.","DOI":"10.1016\/S0021-9258(18)68219-5"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Votruba M, Fitzke FW, Holder GE, Carter A, Bhattacharya SS, Moore AT. Clinical features in affected individuals from 21 pedigrees with dominant optic atrophy. Arch Ophthalmol. 1998; 116:351-358.","DOI":"10.1001\/archopht.116.3.351"},{"key":"13","unstructured":"13. Delettre-Cribaillet C, Hamel CP, Lenaers G. Optic Atrophy Type 1. 2007 Jul 13 [updated 2015 Nov 12]. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews<sup>\u00ae<\/sup> [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2020."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Lenaers G, Reynier P, Elachouri G, Soukkarieh C, Olichon A, Belenguer P, Baricault L, Ducommun B, Hamel C, Delettre C. OPA1 functions in mitochondria and dysfunctions in optic nerve. Int J Biochem Cell Biol. 2009; 41:1866-1874.","DOI":"10.1016\/j.biocel.2009.04.013"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Lenaers G, Hamel C, Delettre C, Amati-Bonneau P, Procaccio V, Bonneau D, Reynier P, Milea D. Dominant optic atrophy. Orphanet J Rare Dis. 2012; 7:46.","DOI":"10.1186\/1750-1172-7-46"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Toomes C, Marchbank NJ, Mackey DA, Craig JE, Newbury-Ecob RA, Bennett CP, Vize CJ, Desai SP, Black GC, Patel N, Teimory M, Markham AF, Inglehearn CF, Churchill AJ. Spectrum, frequency and penetrance of OPA1 mutations in dominant optic atrophy. Hum Mol Genet. 2001; 13:1369-1378.","DOI":"10.1093\/hmg\/10.13.1369"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Yu-Wai-Man P, Griffiths PG, Gorman GS, <i>et al.<\/i> Multi-system neurological disease is common in patients with OPA1 mutations. Brain. 2010; 133:771-786.","DOI":"10.1093\/brain\/awq007"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Brody LC, Mitchell GA, Obie C, Michaud J, Steel G, Fontaine G, Robert MF, Sipila I, Kaiser-Kupfer M, Valle D. Ornithine delta-aminotransferase mutations in gyrate atrophy. Allelic heterogeneity and functional consequences. J Biol Chem. 1992; 267:3302-3307.","DOI":"10.1016\/S0021-9258(19)50731-1"},{"key":"19","unstructured":"19. Genome aggregation database (gnomAD browser). Search for an OAT gene. <i>https:\/\/gnomad.broadinstitute.org<\/i> (accessed March 27, 2021)."},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Delettre C, Griffoin JM, Kaplan J, Dollfus H, Lorenz B, Faivre L, Lenaers G, Belenguer P, Hamel CP. Mutation spectrum and splicing variants in the OPA1 gene. Hum Genet. 2001; 109:584-591.","DOI":"10.1007\/s00439-001-0633-y"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Garafalo AV, Cideciyan AV, H\u00e9on E, Sheplock R, Pearson A, WeiYang Yu C, Sumaroka A, Aguirre GD, Jacobson SG. Progress in treating inherited retinal diseases: Early subretinal gene therapy clinical trials and candidates for future initiatives. Prog Retin Eye Res. 2020; 77:100827.","DOI":"10.1016\/j.preteyeres.2019.100827"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Kaiser-Kupfer MI, de Monasterio FM, Valle D, Walser M, Brusilow S. Gyrate atrophy of the choroid and retina: improved visual function following reduction of plasma ornithine by diet. Science. 1980; 210:1128-1131.","DOI":"10.1126\/science.7444439"}],"container-title":["Intractable &amp; Rare Diseases Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/irdr\/10\/3\/10_2021.01042\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T05:24:35Z","timestamp":1715145875000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/irdr\/10\/3\/10_2021.01042\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,31]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.5582\/irdr.2021.01042","relation":{},"ISSN":["2186-361X","2186-3644"],"issn-type":[{"value":"2186-361X","type":"electronic"},{"value":"2186-3644","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8,31]]},"article-number":"2021.01042"}}